Page last updated: 2024-09-03

gamma-carboline and Degenerative Diseases, Central Nervous System

gamma-carboline has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, J; Dan, W; Wang, J; Zhang, Y1
Aksinenko, AY; Aliev, G; Bachurin, SO; Boltneva, NP; Dubova, LG; Fisenko, VP; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Shevtsova, EF; Sokolov, VB; Vinogradova, DV1

Reviews

1 review(s) available for gamma-carboline and Degenerative Diseases, Central Nervous System

ArticleYear
Recent developments on synthesis and biological activities of γ-carboline.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Carbolines; Humans; Neoplasms; Neuralgia; Neurodegenerative Diseases; Psychophysiologic Disorders

2018

Other Studies

1 other study(ies) available for gamma-carboline and Degenerative Diseases, Central Nervous System

ArticleYear
Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.
    Scientific reports, 2019, 03-19, Volume: 9, Issue:1

    Topics: Acetylcholinesterase; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase; Carbolines; Carboxylesterase; Cholinesterase Inhibitors; Erythrocytes; Horses; Humans; Kinetics; Methylene Blue; Molecular Docking Simulation; Neurodegenerative Diseases; Swine

2019